NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

Cytogenetics and European Leukemia Net (ELN) genetic classification predict patients at increased risk of relapse in acute myeloid leukemia (AML) except in the intermediate risk group for which further prognostic determinants are required. We have previously shown that Natural Killer (NK) cell defec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Rey, Jerome, Borg, Gaelle Bouvier, Gautherot, Emmanuel, Granjeaud, Samuel, Demerle, Clemence, Hamel, Jean-François, Cerwenka, Adelheid, von Strandmann, Elke Pogge, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Olive, Daniel
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564787/
https://ncbi.nlm.nih.gov/pubmed/28548938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17747
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars